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Abstract Spondylodiscitis may arise primarily via hematog-
enous spread or direct inoculation of virulent organisms dur-
ing spine surgery. To date, no comparative data investigating
the differences between primary and postoperative
spondylodiscitis is available. Thus, the purpose of this retro-
spective study was to investigate differences between these two
etiologies. One hundred fifty-nine patients that were treated at
our department were included in the retrospective analysis. The
patients were categorized into two groups based on the etiology
of spondylodiscitis: group NS, primary spondylodiscitis without
prior spinal surgery; group S, spondylodiscitis following spinal
surgery. Evaluation included magnetic resonance imaging
(MRI), laboratory values, clinical outcome, and operative or
conservative management. Preoperative MRI showed higher
rates of epidural and paraspinal abscess in patients with primary
spondylodiscitis (p < 0.005). Vertebral bone destruction was
more severe in group NS (p < 0.05). Survival rate in group S
(98.2%) was higher than in group NS (87.5%, p = 0.024). The
extent of the operative procedure in patients whowere surgically
treated (n = 116) differed between the two groups (p < 0.005). In
conclusion, spondylodiscitis is a life-threatening and serious
disease and requires long-term treatment. Primary
spondylodiscitis is frequently associated with epidural and
paraspinal abscess, vertebral bone destruction and has a higher
mortality rate than postoperative spondylodiscitis. Therefore,
primary spondylodiscitis shows a more severe course than
spondylodiscitis following spine surgery.
Keywords Postoperative spondylodiscitis . Primary
spondylodiscitis .Discitis . Epidural abscess . Spinal infection
Introduction
The incidence of spondylodiscitis is rising probably due to an
aging population, chronic immune-compromising diseases,
frequent spine procedures, and the incessant advancement
of diagnostics [1]. A spondylodiscitis may arise primarily
through hematogenous spread or direct inoculation of virulent
organisms during spine surgery, epidural injections, nerve
root block, or discography [2]. Patients suffering from
spondylodiscitis have increased long-term mortality. Thus, it
is a life-threatening and serious disease [3]. Due to the increas-
ing incidence of spondylodiscitis, there is an urgent need for
further investigations. To best of our knowledge, no compara-
tive data examining potential differences between primary and
postoperative spondylodiscitis is available. Thus, the purpose
of the present retrospective study was to detect differences
between these two etiologies in clinical features, magnetic res-
onance imaging (MRI), outcome, and operative management.
Material and methods
A retrospective review of patients who underwent treatment
for spondylodiscitis between 2010 and 2016 at our department
was performed. One hundred fifty-nine patients were identi-
fied and their data were retrospectively investigated. The
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patients were then categorized into two groups based on
the etiology of spondylodiscitis: group NS, primary
spondylodiscitis without prior spinal surgery; group S,
spondylodiscitis due to spinal surgery. Data were collected
using the patients’ health records and MRI. MRI was read
by an independent neuroradiologist, blinded to the patients’
clinical data. C-reactive protein (CRP) and complete white
cell count were analyzed routinely. Patients with neurological
deficits, progressive pain, or progression in MRI despite con-
servative treatment underwent surgical treatment. Each treat-
ment option was accompanied by broad-spectrum antibiotic
therapy or antibiotics according to the antiobiogram when
available. Patients were treated with intravenous broad-
spectrum antibiotics for a short period of time (2 to 6
weeks) followed by oral antibiotics for a total period of
3 months. After initial diagnosis, data of conservatively
(cS, cNS) or surgically (sS, sNS) treated patients were ana-
lyzed separately (Fig. 1). In surgically treated patients
(n = 117), the two groups were compared at the time of
the initial diagnosis, the day of admission, on the third
postoperative day, before discharge, and after 6 and 12
months follow-up. The surgical approach and technique was
determined for each patient individually according to the pres-
ent comorbidities, location, extent of infection, and bony de-
struction. Options used are described in Table 1. In conserva-
tively treated patients (n = 43), the two groups were compared
at the time of initial diagnosis, 3 and 14 days, and 1.5 and 3
months after initial diagnosis. Long-term follow-up was not
available in conservatively treated patients, as follow-up is usu-
ally terminated as soon as CRP values normalized and clinical
complaints are relieved.
Statistical analysis
All patients with complete initial data were considered for
inclusion in the retrospective analysis. All values are
expressed as mean ± SD. The Kolmogorov-Smirnov test was
used for testing for normal distribution. The unpaired Student’s
t test and Mann-Whitney U test were used to analyze
differences in clinical and demographic characteristics and in
clinical outcome variables. Frequencies were compared by chi-
square and Fisher’s exact tests. Spearman’s rho correlation (r)
was performed to assess the relation of clinical outcome and
MRI findings. A p value <0.05 was considered statistically
significant. All statistical evaluations were performed with
SPSS Version 21.0 (IBM Corp. Released 2012. IBM SPSS
Statistics for Windows, Version 21.0, NY: IBM Corp.).
Figures were designed using GraphPad Prism (version 5.0 for
Mac OS X, GraphPad Software, La Jolla, CA, USA, www.
graphpad.com).
Results
The demographic details and patients’ characteristics are
presented in Table 2. One hundred fifty-nine patients who
underwent surgical and conservative treatment for
spondylodiscitis have been identified at the Department of
Neurosurgery. Thereby, the proportion of spondylodiscitis fol-
lowing surgery was 35% (group S, n = 55) versus 65% (group
NS, n = 104) for primary spondylodiscitis. Altogether, 73/159
(46%) patients were female. The most common ASA score
was ASA 3° in both groups (p > 0.05). Drug abuse was more
common in group NS (23/104 (22%); p = 0.041). A dorsal
decompression was initially performed in 67% of patients in
group S. The infection was mostly located in the lumbar spine
followed by the thoracic and cervical spine.
Preoperative MRI showed higher rates of epidural and
paraspinal abscess in patients with primary spondylodiscitis
(p < 0.05). Vertebral bone destruction was more severe in
group NS (31% less than 75% of bone left) than in group S
(12% less than 75% of bone left; p = 0.020). There was no
difference in disc destruction between the two groups
Fig. 1 Flow chart on the
treatment in all patients with
primary (NS) and secondary
acquired spondylodiscitis (S).




Table 1 The surgical approach
and method of spinal surgery in








Cervical fusion—anterior, n (%) 1/47 (2) 4/69 (6)
Cervical fusion—posterior, n (%) 1/47 (2) 2/69 (3)
Cervical corpectomy without dorsal instrumentation, n (%) 0/47 (0) 8/69 (11)
Cervical corpectomy with dorsal instrumentation, n (%) 1/47 (2) 2/69 (3)
Thoracic fusion, n (%) 4/47 (8) 9/69 (13)
Thoracic corpectomy with instrumentation, n (%) 1/47 (2) 6/69 (9)
Lumbar instrumentation, n (%) 35/47 (74) 32/69 (46)
Lumbar corpectomy with instrumentation, n (%) 2/47 (4) 2/69 (3)
Lumbar anterior instrumentation, n (%) 0/47 (0) 1/69 (1)
Debridement without instrumentation, n (%) 2/47 (4) 3/69 (4)
Corpectomies were more often performed in primary spondylodiscitis
n number of patients, sS secondary acquired spondylodiscitis surgically treated, sNS primary acquired
spondylodiscitis surgically treated
Table 2 Demographic details in








Age In years 66.4 ± 11 64.6 ± 12 n.s.
Female gender, (%) 29/55 (52) 57/104 (54) n.s.
BMI 26.2 ± 3 26.0 ± 6 n.s.
ASA score, n (%) 1° 4/55 (7) 10/104 (9) n.s.
2° 21/55 (38) 24/104 (23) n.s.
3° 28/55 (51) 61/104 (58) n.s.
4° 2/55 (3) 9/69 (8) n.s.
Duration of hospital stay In days 15.8 ± 10.1 10.5 ± 9.7 0.000
Comorbidities Depression, n (%) 9/55 (16) 6/104 (6) 0.030
Renal failure, n (%) 7/55 (12) 18/104 (17) n.s.
Diabetes, n (%) 10/55 (18) 19/104 (18) n.s.
Heart diseases, n (%) 19/55 (34) 35/104 (34) n.s.
Hepatopathy, n (%) 6/55 (11) 19/104 (18) n.s.
Dental disease, n (%) 1/55 (2) 6/104 (6) n.s.
Addiction Smoking, n (%) 11/55 (20) 15/104 (14) n.s.
Cigarettes per day 3.9 ± 10 3.0 ± 8 n.s.
Alcohol, n (%) 10/55 (18) 33/104 (32) n.s.
Drug abuse, n (%) 5/55 (9) 23/104 (22) 0.041
Initial operative procedure Dorsal decompression, n (%) 37/55 (67) 0/104 (0)
Dorsal fusion surgery, n (%) 13/55 (24) 0/104 (0)
Cervical fusion (Cloward), n (%) 3/55 (5) 0/104 (0)
Kyphoplasty, n (%) 2/55 (4) 0/104 (0)
Location of spondylodiscitis Cervical, n (%) 3/55 (5) 18/104 (17) n.s.
Thoracic, n (%) 8 /55 (14) 23/104 (22)
Lumbar, n (%) 42/55 (76) 52/104 (50)
Cervical and thoracic, n (%) 0/55 (0) 1/104 (1)
Cervical and lumbar, n (%) 0/55 (0) 1/104 (1)
Thoracic and lumbar, n (%) 2/55 (4) 9/104 (9)
n number of patients, S secondary acquired spondylodiscitis, NS primary acquired spondylodiscitis, Sig. signif-
icant differences, n.s. not significant
Neurosurg Rev
(p > 0.523) (Fig. 2). The occurrence of an epidural abscess
correlated significantly with the occurrence of a paraspinal
abscess: r = +0.260, p = 0.002, but did not correlate with
vertebral bone destruction (p > 0.05). A significant correlation
could be shown between a paraspinal abscess and vertebral
bone destruction (r = +0.168, p = 0.046). Vertebral bone de-
struction tends to be more severe in patients with
Staphylococcus aureus infection: in 25 vs. 33% of patients
less than 75% of bone was left (p > 0.05).
The duration of hospital stay was longer in the patients who
underwent prior surgery (15.8 ± 10 vs. 10.5 ± 9 days;
p = 0.000). Survival rate in group S (98.2%) was higher than
in group NS (87.5%, p = 0.024; Fig. 1). Patients with an
epidural abscess tended to die more frequently than patients
without: 10 vs. 5% (p > 0.05). Vertebral bone destruction
correlated significantly with the rate of death: r = +0.047,
p = 0.003. Thereby, the duration from the first diagnosis to
death was 50.8 ± 72 days in surgically treated patients and
24.8 ± 21 days in conservatively treated patients (p > 0.05).
For more details, see Fig. 1. Sepsis was detected more often in
group NS (30%) than in group S (15%), although this was not
statistically significant (p = 0.056). S. aureus presented the
most common organism in intraoperative smear test and blood
culture (Table 3), without significant microbiological differ-
ences between the groups (p > 0.05).
In surgically treated patients (sS, sNS) significant differ-
ences were found in the extent of the operative procedure as
described in Table 1 (p < 0.005), especially corpectomies were
more often performed in group sNS than in group sS
(p = 0.017). Duration of the first diagnosis until surgery was
15.8 ± 10 days in group sS and 15.8 ± 25 days in group sNS
(p > 0.05). 64% in group sS and 67% in group sNS received
primary conservative treatment before surgery (p > 0.05).
Overall pain on NRS showed significant improvement after
12 months in both groups (p < 0.005), whereas NRS was
rated significantly higher in group sS than in group sNS
3 months after surgery (p < 0.005) (Fig. 3). Laboratory
parameters in both groups (sS, sNS) decreased significant-
ly after surgery (p < 0.005) (Fig. 4). In conservatively
treated patients (cS, cNS), differences in infection
Fig. 2 Preoperative magnetic resonance imaging finding in all patients. S secondary acquired spondylodiscitis, NS primary acquired spondylodiscitis, p
significance
Table 3 Pathogen spectrum in intraoperative smear test and blood culture in all patients with primary and secondary acquired spondylodiscitis
Group S Group NS
Intraoperative smear test of surgically
treated patients, n (%)
Positive 17/47 (36) 28/69 (41)
Staphylococcus aureus 6/47 (13) 17/69 (25)
Staphylococcus epidermidis 6/47 (13) 3/69 (4)
Escherichia coli 1/47 (2) 2/69 (3)
Others (e.g., Propionibacterium
acnes, Streptococcus gallolyticus)
4/47 (9) 6/69 (9)
Blood culture of all patients, n (%) Positive 13/55 (23) 45/104 (43)
Staphylococcus aureus 4/55 (7) 19/104 (18)
Staphylococcus hominis 1/55 (2) 2/104 (2)
Escherichia coli 2/55 (4) 1/104 (1)
Others (e.g., Propionibacterium acnes,
Streptococcus gallolyticus)
6/55 (8) 23/104 (22)
Staphylococcus aureus presented the most common bacteria
n number of patients, S secondary acquired spondylodiscitis, NS primary acquired spondylodiscitis
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parameters could be shown after 14 days of the first diag-
nosis: CRP: cNS 5.1 ± 6 mg/dL vs. cS 1.4 ± 1, p = 0.08;
leukocytes: cNS 7.3 U/L vs. cS 5.3±1 U/L, p = 0.044
(Fig. 4). No significant differences revealed between
groups in NRS at the first diagnosis or in the follow-up
visits of 3 months (p > 0.05, Fig. 3).
Discussion
The authors present the results of the first retrospective
study investigating the differences between primary and
postoperatively acquired spondylodiscitis. Survival rate
was significantly higher in patients with postoperative
Fig. 3 Overall pain on numeric rating scale (NRS) in a surgically (sS,
sNS) and b conservatively treated patients (cS, cNS). S secondary
acquired spondylodiscitis, NS primary acquired spondylodiscitis, c
conservatively treated, s surgically treated. ★★ƒ: differences in follow-
up: p < 0.005, ★★: differences between groups: p < 0.005. a FD first
diagnosis, A day of admission, 3d third postoperative day, D discharge,
3m and 12m 6m and 12 months follow-up. b FD first diagnosis, d days
after the first diagnosis, m months after the first diagnosis
Fig. 4 Inflammatory blood value
in a surgically (sS, sNS) and b
conservatively treated patients
(cS, cNS). CRP C-reactive






p< 0.005, ★ƒ: differences in
follow-up: p< 0.05, ★:
differences between groups:
p< 0.05. a FD first diagnosis, A
day of admission, 3d third
postoperative day, D discharge,
3m and 12m 6 and 12 months
follow-up. b FD first diagnosis, d
days after the first diagnosis, m
months after the first diagnosis
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spondylodiscitis. MRI remains the most sensitive and spe-
cific imaging modality to detect spondylodiscitis and the
infection of the adjacent tissue [4]. Epidural and paraspinal
abscess and vertebral bone destruction was more severe in
primary spondylodiscitis. Surgical treatment accompanied
by broad-spectrum antibiotics resulted in significant reduc-
tion of overall pain and inflammatory blood values
12 months after surgery. No significant pain decrease
could be detected in conservatively treated patients
3 months after the first diagnosis.
Infective spondylodiscitis can result in disc destruction, path-
ological fractures and abscess formations. A spinal epidural
abscess is an infection involving the epidural space and has a
high mortality rate [5]. Once a rare diagnosis carrying a poor
prognosis, its incidence is rising dramatically. The development
of an epidural abscess may be associated with various risk fac-
tors, such as advanced age over 65 years, immunocompromized
state, smoking or diabetes mellitus. Furthermore, intravenous
drug abuse has been associated with a high prevalence of epi-
dural abscess commonly due to hematogeneous bacterial spread
[6–9]. Drug abuse was more common in the patients who de-
veloped a primary spondylodiscitis. This could be a fundamen-
tal reason for the higher occurrence of epidural abscess in these
patients and particularly for the higher mortality rate that is
closely associated to infections with abscess formation [3, 10].
An epidural abscess may be associated with significant bone
destruction resulting in instability and deformity of the spine
[11]. In our study group, a significant correlation could not be
shown, whereas a paraspinal abscess may induce vertebral bone
loss. Instability establishes a major risk factor for developing a
potentially neurological impairment. Then early surgical stabi-
lization is insistently recommended to preserve neurological
function [12]. Furthermore, vertebral bone destructionwasmore
severe in primary spondylodiscitis, whereas differences in disc
destruction did not occur between the two groups [11].
The most common causative organism in spondylodiscitis
is Staphylococcus aureus which is responsible for widespread
bone loss and bone destruction [13, 14]. Additionally, an in-
creased long-term mortality rate, mainly due to sepsis, is re-
ported in adult patients suffering from Staphylococcus aureus
spondylodiscitis [14]. Thus, early surgical debridement is ob-
tained to reduce the bacterial load and improve the antibiotic
efficacy, especially in multiresistant Staphylococcus aureus
infection [15]. Further causative organisms have been de-
scribed and increased over the last few years, especially
gram-negative bacteria. An important cause is the use of rou-
tine use of prophylactic antibiotics after spinal surgery [16].
Nevertheless, the pathogen that is responsible for
spondylodiscitis can only be identified in approximately 35
to 50% of cases [17, 18]. In our retrospective series the path-
ogen could only be detected in 26% of blood culture and 39%
of intraoperative smear test samples. This may be due to the
fact that broad spectrum antibiotics have been applied in our
outpatient clinics before a spondylodiscitis could be diag-
nosed accurately.
Surgery is indicated for neurological impairment, deformi-
ty, instability, medical intractable pain, and disease progres-
sion [19, 20]. The surgical goals are the debridement of infec-
tion, identification of pathogens, decompression of neuronal
structures, and stabilization of deformed and instable seg-
ments. Depending on the location and extent of infection,
various treatment options for spondylodiscitis are available.
There is still controversy regarding the most adequate surgical
approach [20–24]. Nevertheless, fusion is recommended in
discitis with involvement of endplates of the vertebral body,
whereas in intraspinal empyema dorsal decompression and
evacuation alone may be sufficient [20]. Significant differ-
ences occurred in the extent of operative procedures in our
study group. A higher spread of infection resulted in a more
aggressive surgery. Cervical and thoracal corpectomy was
performed more frequently in patients with primary
spondylodiscitis. A minor part of patients were treated with
debridement only because spondylodiscitis with liquefaction
of endplates was present in over 90% of patients. Furthermore,
patients who already had surgery were presumably screened
earlier for spondylodiscitis as their counterparts. This may due
to the fact that these patients are followed up routinely after
their surgical treatment and therefore infection may be detect-
ed earlier in the infectious cascade.
In conclusion spondylodiscitis is a life-threatening and se-
rious disease and requires long-term treatment. Our retrospec-
tive analysis demonstrates a significantly higher mortality
rate in patients with primary spondylodiscitis. Primary
spondylodiscitis is frequently associated with epidural and
paraspinal abscesses and vertebral bone destruction. Thus, it
seems that primary spondylodiscitis shows a more severe
course than spondylodiscitis following spine surgery.
Nevertheless, with current standards, prospective clinical tri-
als will be mandatory to better understand the pathogenesis of
spondylodiscitis and furthermore develop evidence-based
treatment recommendations for these patients.
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